Jill Williams

Summary

Affiliation: New Jersey
Country: USA

Publications

  1. doi request reprint A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder
    Jill M Williams
    Division of Addiction Psychiatry, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
    J Clin Psychiatry 73:654-60. 2012
  2. pmc Varenicline for tobacco dependence: panacea or plight?
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School, 317 George St, Suite 105, 08901, New Brunswick, New Jersey, USA
    Expert Opin Pharmacother 12:1799-812. 2011
  3. pmc A comprehensive model for mental health tobacco recovery in new jersey
    Jill M Williams
    Division of Addiction Psychiatry, UMDNJ Robert Wood Johnson Medical School, 317 George Street, Suite 105, New Brunswick, NJ, USA
    Adm Policy Ment Health 38:368-83. 2011
  4. ncbi request reprint Use of caffeine and nicotine in people with schizophrenia
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
    Curr Drug Abuse Rev 1:155-61. 2008
  5. ncbi request reprint Smoking, drugs, and other behavioral health problems among multiethnic adolescents in the NHSDA
    William A Vega
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ 08854, United States
    Addict Behav 32:1949-56. 2007
  6. ncbi request reprint Using peer counselors to address tobacco use: the CHOICES program
    Jill M Williams
    Division of Addiction Psychiatry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 317 George St, Suite 105, New Brunswick, NJ 08901, USA
    Psychiatr Serv 58:1225. 2007
  7. doi request reprint Eliminating tobacco use in mental health facilities: patients' rights, public health, and policy issues
    Jill M Williams
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
    JAMA 299:571-3. 2008
  8. doi request reprint Tobacco use among individuals with intellectual or developmental disabilities: a brief review
    Marc L Steinberg
    Department of Psychiatry, Robert Wood Johnson Medical School, New Brunswick, NJ, USA
    Intellect Dev Disabil 47:197-207. 2009
  9. pmc Higher serum caffeine in smokers with schizophrenia compared to smoking controls
    Kunal K Gandhi
    Department of Psychiatry, Division of Addiction Psychiatry, UMDNJ, Robert Wood Johnson Medical School, 317 George St, Suite 105, New Brunswick, NJ 08901, United States
    Drug Alcohol Depend 110:151-5. 2010
  10. pmc Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ 08901 2008, USA
    J Subst Abuse Treat 38:384-93. 2010

Detail Information

Publications30

  1. doi request reprint A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder
    Jill M Williams
    Division of Addiction Psychiatry, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
    J Clin Psychiatry 73:654-60. 2012
    ..We evaluated the safety and efficacy of varenicline for smoking cessation in outpatients with stable schizophrenia or schizoaffective disorder...
  2. pmc Varenicline for tobacco dependence: panacea or plight?
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School, 317 George St, Suite 105, 08901, New Brunswick, New Jersey, USA
    Expert Opin Pharmacother 12:1799-812. 2011
    ....
  3. pmc A comprehensive model for mental health tobacco recovery in new jersey
    Jill M Williams
    Division of Addiction Psychiatry, UMDNJ Robert Wood Johnson Medical School, 317 George Street, Suite 105, New Brunswick, NJ, USA
    Adm Policy Ment Health 38:368-83. 2011
    ....
  4. ncbi request reprint Use of caffeine and nicotine in people with schizophrenia
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
    Curr Drug Abuse Rev 1:155-61. 2008
    ..This paper reviews use of caffeine and nicotine in people with schizophrenia and gives recommendations for their further study...
  5. ncbi request reprint Smoking, drugs, and other behavioral health problems among multiethnic adolescents in the NHSDA
    William A Vega
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ 08854, United States
    Addict Behav 32:1949-56. 2007
    ..African American and Hispanic immigrants had lower risk of smoking initiation and tobacco dependence, however, ethnic group adolescents who initiated smoking shared increased risk of addictive and non-addictive disorders...
  6. ncbi request reprint Using peer counselors to address tobacco use: the CHOICES program
    Jill M Williams
    Division of Addiction Psychiatry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 317 George St, Suite 105, New Brunswick, NJ 08901, USA
    Psychiatr Serv 58:1225. 2007
  7. doi request reprint Eliminating tobacco use in mental health facilities: patients' rights, public health, and policy issues
    Jill M Williams
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
    JAMA 299:571-3. 2008
  8. doi request reprint Tobacco use among individuals with intellectual or developmental disabilities: a brief review
    Marc L Steinberg
    Department of Psychiatry, Robert Wood Johnson Medical School, New Brunswick, NJ, USA
    Intellect Dev Disabil 47:197-207. 2009
    ..Suggestions for additional avenues of inquiry as well as modifications to current cessation treatments are proposed...
  9. pmc Higher serum caffeine in smokers with schizophrenia compared to smoking controls
    Kunal K Gandhi
    Department of Psychiatry, Division of Addiction Psychiatry, UMDNJ, Robert Wood Johnson Medical School, 317 George St, Suite 105, New Brunswick, NJ 08901, United States
    Drug Alcohol Depend 110:151-5. 2010
    ..Clinical effects of smoking and caffeine intake are important and may complicate the interpretation of schizophrenia symptoms and antipsychotic medication side effects, thus warranting further research...
  10. pmc Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ 08901 2008, USA
    J Subst Abuse Treat 38:384-93. 2010
    ..Findings support that mental health clinicians can be trained to effectively help smokers with SCZ maintain tobacco abstinence...
  11. pmc Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette
    Jill M Williams
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08901 2008, USA
    Nicotine Tob Res 12:855-9. 2010
    ..The increase in blood nicotine after smoking a single cigarette is nicotine boost. We hypothesized that smokers with schizophrenia (SCZ) have a greater nicotine boost than controls without this disorder...
  12. pmc Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School, 317 George Street, Suite 105, New Brunswick, NJ 08901 2008, USA
    Cancer Epidemiol Biomarkers Prev 19:2582-9. 2010
    ..Antiepileptic drugs (AED) are being increasingly used in the management of serious mental illness, but their effects on nicotine metabolism have not been studied...
  13. doi request reprint Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies
    Michael B Steinberg
    Division of General Internal Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 125 Paterson Street, Suite 2300, New Brunswick, NJ 08903, USA
    Drug Alcohol Depend 114:77-81. 2011
    ..This study evaluated abstinence and psychiatric outcomes of various tobacco dependence medications, including varenicline...
  14. ncbi request reprint Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School and UMDNJ School of Public Health Tobacco Dependence Program, New Brunswick, NJ 08901, USA
    Nicotine Tob Res 9:873-81. 2007
    ..Menthol is an important cigarette additive that may help explain why some groups have lower quit rates and more smoking-caused disease...
  15. ncbi request reprint Serious mental illness and tobacco addiction: a model program to address this common but neglected issue
    Douglas Ziedonis
    Department of Psychiatry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854, USA
    Am J Med Sci 326:223-30. 2003
    ..The unique barriers and clinical issues for this population are described...
  16. ncbi request reprint Addressing tobacco among individuals with a mental illness or an addiction
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School, Division of Addiction Psychiatry, UMDNJ SPH, Tobacco Dependence Program, 317 George Street, Suite 210, New Brunswick, NJ 08901, USA
    Addict Behav 29:1067-83. 2004
    ..More research is needed as well as a national organized effort to address tobacco in this large segment of smokers...
  17. ncbi request reprint Applicability of the Fagerström Test for Nicotine Dependence in smokers with schizophrenia
    Marc L Steinberg
    Division of Addiction Psychiatry, UMDNJ Robert Wood Johnson Medical School, UBHC D303, 671 Hoes Lane, Piscataway, NJ 08854, USA
    Addict Behav 30:49-59. 2005
    ..Specific examples of problematic items and how these may contribute to an underestimate of tobacco dependence severity are discussed, as well as ways to modify the FTND to be more appropriate for this population...
  18. ncbi request reprint The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey
    Jill M Williams
    Tobacco Dependence Program, School of Public Health, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA
    J Subst Abuse Treat 28:331-40. 2005
    ..Licensure standards regulation can be an effective mechanism for increasing the quantity and quality of tobacco dependence treatment in residential addictions programs...
  19. ncbi request reprint Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect
    Jill M Williams
    UMDNJ Robert Wood Johnson Medical School, USA
    Schizophr Res 79:323-35. 2005
    ..Our data support the hypothesis that the increased serum nicotine and cotinine levels observed are attributable to an increased nicotine intake per cigarette in smokers with schizophrenia as compared to those without mental illness...
  20. ncbi request reprint Developments in pharmacotherapy for tobacco dependence: past, present and future
    Jonathan Foulds
    University of Medicine and Dentistry of New Jersey, School of Public Health, Tobacco Dependence Program, New Brunswick 08852, USA
    Drug Alcohol Rev 25:59-71. 2006
    ..In addition, there is a need for studies designed to evaluate the efficacy of pharmacotherapies in populations such as youth, pregnant smokers and smokers with co-occurring mental health problems...
  21. ncbi request reprint Factors associated with quitting smoking at a tobacco dependence treatment clinic
    Jonathan Foulds
    Tobacco Dependence Program TDP, University of Medicine and Dentistry of New Jersey UMDNJ School of Public Health SPH, New Brunswick, NJ 08901, USA
    Am J Health Behav 30:400-12. 2006
    ..To identify factors associated with successful quitting at a free tobacco treatment clinic...
  22. ncbi request reprint Successful tobacco dependence treatment in schizophrenia
    Jill M Williams
    Robert Wood Johnson Medical School, Tobacco Dependence Program, 317 George St, Suite 105, New Brunswick, NJ 08901, USA
    Am J Psychiatry 164:222-7; quiz 373. 2007
  23. ncbi request reprint A tobacco treatment model for persons with serious mental illness
    Jill M Williams
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Piscataway, 08854, USA
    Psychiatr Serv 57:1210. 2006
  24. ncbi request reprint A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia
    Jill M Williams
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Piscataway, New Jersey 08855, USA
    Psychiatr Serv 55:1064-6. 2004
    ..Ten patients (83 percent) used the spray in combination with other medications, and all received psychosocial support. Nicotine nasal spray was found to be well tolerated...
  25. pmc Lower task persistence in smokers with schizophrenia as compared to non-psychiatric control smokers
    Marc L Steinberg
    Department of Psychiatry, Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
    Psychol Addict Behav 24:724-9. 2010
    ..Future studies should evaluate the ability of task persistence to predict abstinence from cigarettes prospectively among smokers with schizophrenia...
  26. ncbi request reprint Integrating tobacco dependence treatment and tobacco-free standards into addiction treatment: New Jersey's experience
    Jonathan Foulds
    Tobacco Dependence Program, School of Public Health, University of Medicine and Dentistry of New Jersey UMDNJ, New Brunswick, New Jersey, USA
    Alcohol Res Health 29:236-40. 2006
  27. ncbi request reprint Advances in pharmacotherapy for tobacco dependence
    Jonathan Foulds
    UMDNJ School of Public Health
    Expert Opin Emerg Drugs 9:39-53. 2004
    ..g., frequency of injections required) before they can become widely used and successful therapies. The best hope of improved treatment comes from combining existing and new pharmacotherapies with effective behavioural therapy...
  28. pmc Tobacco use among those with serious psychological distress: results from the national survey of drug use and health, 2002
    Brett T Hagman
    University of Medicine and Dentistry of New Jersey, School of Public Health, Department of Health Education and Behavioral Sciences, Piscataway, New Jersey, United States
    Addict Behav 33:582-92. 2008
    ....
  29. ncbi request reprint Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved
    Jill M Williams
    Behav Healthc 26:27-31. 2006
  30. ncbi request reprint Racial differences in lung cancer
    Jonathan Foulds
    N Engl J Med 354:1951-3; author reply 1951-3. 2006

Research Grants8

  1. Nicotine Dependence Treatment in Psychiatric Comorbidity
    Jill Williams; Fiscal Year: 2005
    ..Techniques from dual diagnosis treatment can be adapted for treating nicotine dependence and include aspects of social skills training, motivational enhancement therapy and relapse prevention. ..
  2. Nicotine Intake in Smokers with Schizophrenia
    Jill Williams; Fiscal Year: 2007
    ....
  3. Nicotine Intake in Smokers with Schizophrenia
    Jill Williams; Fiscal Year: 2009
    ....
  4. R01-Williajm - Double-Blind Placebo-Controlled trial of Nicotine Nasal Spray as a
    Jill M Williams; Fiscal Year: 2010
    ..There is a need to systematically examine available treatments and explore new ones that can address their needs. ..